Filing Details
- Accession Number:
- 0001110803-11-000129
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-22 21:12:51
- Reporting Period:
- 2011-07-20
- Filing Date:
- 2011-07-22
- Accepted Time:
- 2011-07-22 21:12:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1364711 | Christian Cabou | 9885 Towne Centre Drive San Diego CA 92121-1975 | Sr Vp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-07-20 | 8,000 | $37.04 | 38,315 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-07-20 | 5,105 | $71.78 | 33,210 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-07-20 | 2,895 | $72.98 | 30,315 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-20 | 8,000 | $0.00 | 8,000 | $37.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
44,500 | 2010-02-27 | 2020-01-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,000 | Indirect | by Spouse |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 5,105 shares sold ranging from $71.41 to $72.40 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,895 shares sold ranging from $72.54 to $73.26 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.